Navigation Links
5W Public Relations Expands Corporate Practice, Adds PURE Bioscience, Inc. to Client Roster
Date:12/18/2013

NEW YORK, Dec. 18, 2013 /PRNewswire/ -- 5W Public Relations, one of the 25 largest independent public relations firms in the U.S., announced the addition of PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial agent, to its diverse roster of corporate clients.

PURE Bioscience, Inc. is focused on developing and commercializing antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control through its technology platform, which is based on patented stabilized ionic silver. The company's SDC-technology, delivers an antimicrobial agent that destroys germ cells, delivered in a non-toxic, easy-to-use solution that has demonstrated superior efficacy as a disinfectant in food industry applications.

"5WPR is excited to highlight PURE Bioscience, Inc.'s solutions to the health and environmental challenges of pathogen and hygienic control," says Ronn Torossian, CEO, 5W Public Relations. "We believe that we will help garner the recognition that this product's technology deserves."

5W Public Relations will execute the PR campaign focusing on PURE's unique and proprietary SDC-based antimicrobial as an active ingredient in disinfectants and cleaners used in the food industry.

"We are proud of the team we have put together and excited about the positioning of our unique SDC-technology as a proven food safety solution," said Hank Lambert, Chief Executive Officer of PURE. "We are confident that 5W will assist in introducing our technology to the food industry and look forward to working with their team as we enter 2014, a year in which we are expecting tremendous growth."

ABOUT 5W RELATIONS

5W Public Relations (www.5wpr.com) is a full-service public relations agency known for implementing cutting-edge, customized campaigns designed to drive our clients' business goals and objectives. Founded by Ronn Torossian in 2003, the energetic and focused culture earned the agency a spot on the INC. 500 list and recognition as the nation's "fastest-growing PR agency" three years in a row. Our 24/7 approach led the industry's foremost trade magazine to describe 5WPR as "aggressive in a way that clearly resonates with clients looking for a firm staffed with Type A-plus personalities, a BS-free approach, and results from Day One."

About PURE Bioscience, Inc.

PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control within the food industry. Our technology platform is based on patented stabilized ionic silver, and our initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.

CONTACT: Ronn Torossian, 5W Public Relations, 212-999-5585, ronn@5wpr.com


'/>"/>
SOURCE 5W Public Relations
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Caris Life Sciences Receives Patent for Molecular Profiling Service in The Peoples Republic of China
2. CNTS Awarded $40 Million Contract Supporting U.S. Military Through Global Public Health
3. Synthetic Biologics Announces Proposed Public Offering of Common Stock
4. MiMedx Group Announces Proposed Public Offering of Common Stock
5. Xencor Prices Initial Public Offering
6. The Holistic Sanctuary Rebukes The New Republic’s Attempt to Destigmatize Buprenorphine and Suboxone
7. Northwest Biotherapeutics Announces Pricing Of Public Offering Of Common Stock And Warrants
8. Z Trim Holdings, Inc. Closes $1.4 Million Public Offering
9. AbbVie and North Chicago Public Schools Announce $350,000 Grant to Advance Math Education
10. Z Trim Holdings, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
11. DURECT Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... 20, 2017 , ... Nipro Corporation (Osaka, Japan) and Transonic Systems Inc. (New ... receive exclusive marketing and sales rights for all non-OEM Transonic products in Japan. As ... Japan, the new Nipro - Transonic JV is a natural next step to advance ...
(Date:1/21/2017)... , Jan. 21, 2017   Boston Biomedical , ... designed to target cancer stemness pathways, today presented data ... napabucasin, at the 2017 American Society of Clinical Oncology ... . In a Phase Ib/II ... designed to inhibit cancer stemness pathways by targeting STAT3 ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... announced today the next evolution in spinal fusion, the MISquito Percutaneous Pedicle ... to the competition, SpineFrontier is focused on technique driven product solutions that ...
(Date:1/19/2017)... Research and Markets ... announced the addition of the "Implantable Biomaterials Market ... report to their offering. Report Highlights: ... analysis on current and future market trends to identify the investment opportunities ... the base numbers Key market trends across the business ...
Breaking Biology Technology:
(Date:1/12/2017)... research undertaken by Fit Small Business has revealed ... simply asked which office technology had they not used in ... Insights on what will be key features in ... industry leaders including Penelope Trunk , Martin Lindstrom ... Some of these findings included; ...
(Date:1/11/2017)... 2017 Intoxalock, a leading ignition interlock provider, ... its patent-pending calibration device. With this new technology, Intoxalock ... upload data logs and process repairs at service center ... "Fighting drunk driving through the application of cutting-edge technologies ... but also for the customer who can get back ...
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
Breaking Biology News(10 mins):